Bellmead, Texas — According to state and local economic development sources Immunotek Bio Centers plans to invest $1,000,000.00 to build out 9,000 square feet of new space in Bellmead. The company plans to occupy the new space at 974 N. Loop 340 in Bellmead, on or about March 1, 2023. According to the company website ImmunoTek Bio Centers is a biotech company committed to the safe collection of high-quality blood plasma and growth of supply through new center development. At ImmunoTek, our donors make an impact with every life-changing donation they make and are an essential ingredient in providing lifesaving therapies to those patients who desperately need it. All ImmunoTek centers are FDA-regulated and follow strict industry standards and guidelines. Each center is staffed with a highly-trained and friendly team dedicated to the procurement of quality blood plasma. Our teammates are at the heart of everything we do at ImmunoTek and they are devoted to serving our donors in every step of their journey. With nearly 100 years of combined experience in the blood, plasma, and biopharma industries, our leadership team provides the guidance needed for the success of our donors and teammates. ImmunoTeks other specialty is constructing, opening, FDA/EU licensing, and managing multiple plasma collection centers and plasma supply contracts to meet ongoing demand in the plasma proteins therapeutics market in partnership with well-known pharmaceutical companies.

To learn more about Immunotek Bio Centers, visit http://www.immunotek.com/

Company Contact:
Blair McKinney, Chief Operating Officer
bmckinney@immunotek.com
https://www.linkedin.com/in/sbmckinney/
855-631-0734

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved